Evidence map›Paper›PMID 26767559›Full record

ArticleJAMA oncology2016

Evaluating Chemotherapy at the End of Life--Reply.

Holly G Prigerson, Alfred I Neugut, Paul K Maciejewski

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in JAMA oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Holly G PrigersonCenter for Research on End-of-Life Care, Weill Cornell Medical College, New York, New York2Division of Geriatrics and Palliative Medicine, Department of Medicine, Weill Cornell Medical College, New York, New York.
Alfred I NeugutHerbert Irving Comprehensive Cancer Center, Department of Medicine, College of Physicians and Surgeon, New York, New York4Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
Paul K MaciejewskiCenter for Research on End-of-Life Care, Weill Cornell Medical College, New York, New York5Department of Radiology, Weill Cornell Medical College, New York, New York.

Funding

Psychosocial Approaches to Better Understanding & End-Stage Cancer Care (PROTECT)R35CA197730 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Holly Gwen Prigerson · 2015 to 2026
$11.2M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health StatusHealth Status IndicatorsQuality of LifeSurveys and QuestionnairesAntineoplastic AgentsFemaleHumansMaleNeoplasmsPalliative CareTerminal CareAntineoplastic Agents

Identifiers

PMID26767559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.